Relationship of anti β2-glycoprotein I and anti prothrombin antibodies to thrombosis and pregnancy loss in patients with antiphospholipid antibodies

Thrombosis and Haemostasis

Volumn 78, Issue 3, 1997, Pages 1008-1014

  Forastiero, Ricardo R ^a   Martinuzzo, Marta E ^a   Cerrato, Graciela S ^a   Kordich, Lucía C ^b   Carreras, Luis O ^a  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BETA2 GLYCOPROTEIN 1; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PHOSPHOLIPID ANTIBODY; PHOSPHOLIPID BINDING PROTEIN; PROTHROMBIN; SNAKE VENOM; APOLIPOPROTEIN; GLYCOPROTEIN; IMMUNOGLOBULIN G; MEMBRANE PROTEIN;

ADOLESCENT; ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTICLE; AUTOIMMUNITY; BLOOD CLOTTING TEST; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ETIOLOGY; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SPONTANEOUS ABORTION; STATISTICAL ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; VEIN THROMBOSIS; IMMUNOLOGY; PREGNANCY; RETROSPECTIVE STUDY;

ABORTION, SPONTANEOUS; ANTIBODIES, ANTIPHOSPHOLIPID; APOLIPOPROTEINS; BETA 2-GLYCOPROTEIN I; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULIN G; MALE; MEMBRANE GLYCOPROTEINS; PREGNANCY; PROTHROMBIN; RETROSPECTIVE STUDIES;

EID: 0030608864     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1657678     Document Type: Article

References (37)

1. Exner T. Diagnostic methodologies for circulating anticoagulants. Thromb Haemost 1995; 74: 338-44.
2. Harris EN. The Second International Anticardiolipin Standardization Workshop/The Kingston Antiphospholipid Antibody (KAPS) Study Group. Am J Clin Pathol 1990; 94: 476-84.
3. Harris EN. The antiphospholipid syndrome - an introduction. In: Phospholipid-Binding Antibodies. Harris EN, Exner T, Hughes GRV, Asherson RA, eds. Boca Raton, Florida (USA). CRC Press 1991; 373-86.
4. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann Intern Med 1990; 112: 682-98.
5. Vila P, Hernández MC, López-Fernández MF, Batlle J. Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects. Thromb Haemost 1994; 72: 209-13.
6. Finazzi G, Brancaccio V, Moia M, Ciavarella N, Mazzucconi G, Schinco P, Ruggeri M, Pogliani EM, Gamba G, Rossi E, Baudo F, Manotti C, D'Angelo A, Palareti G, De Stefano V, Berrettini M, Barbui T. Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: A four-year prospective study from the Italian registry. Am J Med 1996; 100: 530-6.
7. Thiagarajan P, Shapiro SS, De Marco L. Monoclonal immunoglobulin M λ coagulation inhibitor with phospholipid specificity: Mechanism of a lupus anticoagulant. J Clin Invest 1980; 66: 397-405.
8. Pengo V, Thiagarajan P, Shapiro SS, Heine MJ. Immunologic specificity and mechanism of action of IgG lupus anticoagulant. Blood 1987; 70: 69-76.
9. Rauch J, Tannenbaum H, Janoff AS. Distinguishing plasma lupus anticoagulants from antifactor antibodies using hexagonal (II) phase phospholipids. Thromb Haemost 1989; 62: 892-6.
10. 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87: 4120-4.
11. Galli M, Comfurius P, Maassen C, Hemker HC, de Baets MH, van Breda-Vriesman PJC, Barbui T, Zwaal RFA, Bevers EM. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990; 335: 1544-7.
12. 2-glycoprotein I as an antigen. J Immunol Methods 1991; 143: 223-9.
13. 2-glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J Med 1992; 93: 181-6.
14. Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Suzuki T, Sumida T, Yasuda T, Koike T. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J Immunol 1992; 148: 3885-91.
15. 2-rglycoprotein I clearly differentiates anticardiolipin antibodies from antiphospholipid syndrome and syphilis. Thromb Haemost 1996; 75: 717-20.
16. Arvieux J, Darnige L, Caron C, Reber G, Bensa JC, Colomb MG. Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants. Thromb Haemost 1995; 74: 1120-5.
17. Bevers EM, Galli M, Barbui T, Comfurius P, Zwaal RFA. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost 1991; 66: 629-32.
18. Pierangeli SS, Harris EN, Gharavi AE, Goldsmith G, Branch DW, Dean WL. Are immunoglobulins with lupus anticoagulant activity specific for phospholipids? Br J Haematol 1993; 85: 124-32.
19. Ginsberg JS, Wells PS, Brill-Edwards P, Donovan D, Moffatt K, Johnston M, Stevens P, Hirsh J. Antiphospholipid antibodies and venous thromboembolism. Blood 1995; 86: 3685-91.
20. 2-glycoprotein I: Detection and association with thrombosis. Br J Haematol 1995; 89: 397-402.
21. Vaarala O, Puurunen M, Mänttäri M, Manninen V, Aho K, Palosuo T. Antibodies to prothrombin imply a risk of myocardial infarction in middle-aged men. Thromb Haemost 1996; 75: 456-9.
22. 2-glycoprotein I-dependent antiphospholipid antibodies. Blood 1995; 86: 617-23.
23. Forastiero RR, Cerrato GS, Carreras LO. Evaluation of recently described tests for detection of the lupus anticoagulant. Thromb Haemost 1994; 72: 728-33.
24. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: An update. Thromb Haemost 1995; 74: 1185-90.
25. Roubey RAS. Autoantibodies to phospholipid-binding plasma proteins: A new view of lupus anticoagulants and other "antiphospholipid" autoantibodies. Blood 1994; 84: 2854-67.
26. Triplett DA, Antiphospholipid-protein antibodies: laboratory detection and clinical relevance. Thromb Res 1995; 78: 1-31.
27. 2-GPI) enhances cardiolipin binding activity but is not the antigen for antiphospholipid antibodies. Br J Haematol 1992; 82: 565-70.
28. 2-GPI are two distinct populations of autoantibodies. Thromb Haemost 1996; 75: 303-8.
29. Pengo V, Biasiolo A, Brocco T, Tonetto S, Ruffatti A. Autoantibodies to phospholipid-binding plasma proteins in patients with thrombosis and phospholipid-reactive antibodies. Thromb Haemost 1996; 75: 721-4.
30. 2-glycoprotein I antibodies: a marker of antiphospholipid syndrome? Lupus 1995; 4: 122-30.
31. 2-glycoprotein I than with antiphospholipid antibodies. J Rheumatol 1995; 22: 1899-906.
32. 2-glycoprotein I antibodies in autoimmune patients. Clin Exp Immunol 1994; 95: 310-5.
33. 2-glycoprotein I autoantibodies and its relevance to anticardiolipin antibody quantitation. Thromb Haemost 1996; 75: 725-30.
34. Horbach DA, Oort EV, Donders RCJM, Derksen RHWM, de Groot PG. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Thromb Haemost 1996; 76: 916-24.
35. Carreras LO, Forastiero RR. Pathogenic role of antiprotein-phospholipid antibodies. Haemostasis 1996; 26: 340-57.
36. Arnout J. The pathogenesis of the amiphospholipid syndrome: A hypothesis based on parallelisms with heparin-induced thrombocytopenia. Thromb Haemost 1996; 75: 536-41.
37. 2-glycoprotein I in the expression of lupus anticoagulant activity. Blood 1994; 83: 2878-92.